This indicator provides the percentage of long-term care residents taking antipsychotic drugs without a diagnosis of psychosis.
Lower is better; it means that a lower percentage of long-term care residents received antipsychotic medication without a diagnosis of psychosis.
Data availability:
to (fiscal years)
Geographic coverage
Newfoundland and Labrador, New Brunswick, Nova Scotia, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon
Reporting level
Province/Territory, Region, Facility, Corporation
Calculation
This indicator examines the percentage of residents on antipsychotics without a diagnosis of psychosis. It is calculated by dividing the number of residents who received antipsychotic medication by the number of all residents with valid assessments (excluding those with schizophrenia, Huntington's chorea, delusions and hallucinations, and end-of-life residents) within the applicable time period.
Unit of Analysis: Resident
Denominator
Residents with valid assessments
Numerator
Residents who received antipsychotic medication on their target assessment
Comments
The long-term care quality indicators use 4 rolling quarters of data for calculations in order to have a sufficient number of assessments for risk adjustment. Since residents are assessed on a quarterly basis, each resident can contribute to the indicator up to 4 times.
General criteria for public reporting of long-term care indictors in Your Health System are as follows:
Data for this indicator is also available in the Quick Stats product Profile of Residents in Residential and Hospital-Based Continuing Care, which includes province-/territory-level results for both the residential and hospital-based continuing care sectors. Please consult the Quick Stats product for more information.